Idera Pharmaceuticals Buy Hold or Sell Recommendation
| IDRADelisted Stock | USD 0.43 0.05 10.42% |
Given the investment horizon of 90 days and your typical level of risk aversion, our recommendation regarding Idera Pharmaceuticals is 'Not Rated'. Macroaxis provides Idera Pharmaceuticals buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding IDRA positions. The advice algorithm takes into account all of Idera Pharmaceuticals' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Idera Pharmaceuticals' buy or sell advice are summarized below:
Real Value 0.38 | Hype Value 0.43 | Market Value 0.43 | Naive Value 0.42 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Idera Pharmaceuticals given historical horizon and risk tolerance towards Idera Pharmaceuticals. When Macroaxis issues a 'buy' or 'sell' recommendation for Idera Pharmaceuticals, the advice is generated through an automated system that utilizes algorithms and statistical models.
Idera |
Execute Idera Pharmaceuticals Buy or Sell Advice
The Idera recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Idera Pharmaceuticals. Macroaxis does not own or have any residual interests in Idera Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Idera Pharmaceuticals' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Idera Pharmaceuticals Trading Alerts and Improvement Suggestions
| Idera Pharmaceuticals is not yet fully synchronised with the market data | |
| Idera Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Idera Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Idera Pharmaceuticals currently holds about 24.48 M in cash with (24.6 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.46, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 30.0% of the company shares are held by company insiders |
Idera Pharmaceuticals Returns Distribution Density
The distribution of Idera Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Idera Pharmaceuticals' future price movements. The chart of the probability distribution of Idera Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use Idera Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Idera Pharmaceuticals returns is essential to provide solid investment advice for Idera Pharmaceuticals.
| Mean Return | 0.58 | Value At Risk | -10.81 | Potential Upside | 17.86 | Standard Deviation | 9.35 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Idera Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Idera Pharmaceuticals Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Idera . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Idera Pharmaceuticals Buy or Sell Advice
When is the right time to buy or sell Idera Pharmaceuticals? Buying financial instruments such as Idera Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Idera Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Tech Funds Thematic Idea Now
Tech Funds
Funds or Etfs that invest in companies involved in research, development, testing, or distribution of technologically based goods and services. The Tech Funds theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Tech Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Consideration for investing in Idera Stock
If you are still planning to invest in Idera Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Idera Pharmaceuticals' history and understand the potential risks before investing.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |